# CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

> **NCT02331693** · PHASE1 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Glioma

## Interventions

- **BIOLOGICAL:** anti-EGFR CAR T

## Key facts

- **NCT ID:** NCT02331693
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02331693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02331693, "CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02331693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*